National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -7 of 7         results per page
View Search Criteria | Help With Results
           
Last Modified: 9/17/2008     First Published: 2/20/2004  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Prevention


Active


40 to 80


NCI


UARIZ-00-0430-01
00-0430-01, UARIZ-HSC-00142, NCT00078897

First Published: 6/25/2008  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Natural history/Epidemiology, Prevention


Active


50 and over


NCI


SWOG-S0000D
S0000D, NCT00706121

First Published: 1/22/2009  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Prevention


Approved-not yet active


18 and over


NCI


NU-NWU06-8-01
NWU06-8-01, NWU-06-8-01, NCI-06-8-01, NCT00828984

Last Modified: 10/12/2007     First Published: 4/23/2007  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Prevention


Active


Under 75


NCI


NU-NWU04-2-03
NWU04-2-03, NCT00468910

Last Modified: 1/19/2007     First Published: 11/18/2005  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Prevention


Active


16 and over


NCI


MDA-DM-02592
NCT00258219

Last Modified: 4/23/2008     First Published: 11/5/2007  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Biomarker/Laboratory analysis, Prevention


Active


Adult


NCI


NCI-05-C-N215
05-C-N215, NCT00339469

First Published: 4/3/2008  

7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Behavioral study, Biomarker/Laboratory analysis, Prevention


Active


50 and over


NCI


VU-VICC-GI-0810
VICCGI0810, VU-VICC-061020, NCT00653484

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov